Glucocorticoids and progression of breast cancer

Cancer Biology and Therapy

Volumn 4, Issue 12, 2005, Pages 1415-1416

  Herr, Ingrid ^a,b   Marme, Alexander ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Chemotherapy; Corticosteroids; Emesis; Metastases; Nausea; Renal cell carcinoma; Taxane

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; DOCETAXEL; GLUCOCORTICOID; PACLITAXEL; TAXANE DERIVATIVE; TRASTUZUMAB;

ACUTE TOXICITY; BRAIN METASTASIS; BREAST CANCER; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CLINICAL TRIAL; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG MECHANISM; HEART METASTASIS; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPHOMA; METASTASIS; NAUSEA; NONHUMAN; NOTE; SKIN CANCER; SOLID TUMOR; SPLEEN CANCER; VISCERAL METASTASIS;

EID: 31144456574     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.4.12.2354     Document Type: Note

References (20)

1. Ghersi D, Wilcken N, Simes RJ. A systematic review of taxane-containing regimens for metastatic breast cancer. Br J Cancer 2005; 93:293-301.
2. Bernard-Marty C, Cardoso F, Piccart MJ. Use and abuse of taxanes in the management of metastatic breast cancer. Eur J Cancer 2003; 39:1978-89.
3. Coleman RE. Glucocorticoids in cancer therapy. Biotherapy. 1992; 4:37-44.
4. Fidler IJ, Gersten DM, Kripke ML. Influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities. Cancer Res 1979; 39:3816-21.
5. Gorelick E, Segal S, Feldman M. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity. JNCI 1980; 65:1257-64.
6. Seshadri M, Poduval TB, Sundaram K. Studies on metastases. I. Role of sensitization and immunosuppression. JNCI 1979; 63:1205-9.
7. Sherlock P, Hartmann WH. Adrenal steroids and the pattern of metastases of breast cancer. JAMA 1962; 181:313-7.
8. Haid M. Steroid antiemesis may be harmful. N Engl J Med 1981; 304:1237.
9. Iversen HG, Hjort GH. The influence of corticoid steroids on the frequency of spleen metastases in patients with breast cancer. Acta Pathol Microbiol Scand 1958; 44:205-12.
10. Sorensen HT, Mellemkjaer L, Nielsen GL, Baron JA, Olsen JH, Karagas MR. Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst 2004; 96:709-11.
11. Sloman JC, Murphy MJ, Jr. Dexamethasone-induced increase in in vitro clonogenicity of human neoplasms. J Clin Oncol 1984; 2:944-7.
12. Zhang C, Wenger T, Mattern J, et al. Glucocorticoids protect various solid tumors but not lymphoid cancer cells from cytotoxic therapy. 2005; Submitted.
13. Kull FC, Jr. Reduction in tumor necrosis factor receptor affinity and cytotoxicity by glucocorticoids. Biochem Biophys Res Commun 1988; 153:402-9.
14. Feng Z, Marti A, Jehn B, Altermatt HJ, Chicaiza G, Jaggi R. Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J Cell Biol 1995; 131:1095-103.
15. Mikosz CA, Brickley DR, Sharkey MS, Moran TW, Conzen SD. Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1. J Biol Chem 2001; 276:16649-54.
16. Messmer UK, Pereda-Fernandez C, Manderscheid M, Pfeilschifter J. Dexamethasone inhibits TNF-alpha-induced apoptosis and LAP protein downregulation in MCF-7 cells. Br J Pharmacol 2001; 133:467-76.
17. Pang D, Kocherginsky M, Conzen SD. Dexamethasone decreases xenograft response to paclitaxel through inhibition of tumor cell apoptosis. Cancer Res 2005; In press.
18. Sui M, Chen F, Fan W. Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors. Int J Cancer 2005; In press.
19. Rasmuson T, Ljungberg B, Grankvist K, Jacobsen J, Olsson T. Increased serum cortisol levels are associated with high tumour grade in patients with renal cell carcinoma. Acta Oncol 2001; 40:83-7.
20. Rutz HP, Hofer S, Peghini PE, Gutteck-Amsler U, Rentsch K, Meier-Abt PJ, Meier UR Bernays RL. Avoiding glucocorticoid administration in a neurooncological case. Cancer Biol Ther 2005; This issue.